Finnish company Surgify Medical has secured €7m ($7.97m) in Series A funding to expand the reach of its Surgify Halo technology, which aims to enhance the precision and safety of bone surgery.
ZEISS Ventures spearheaded the funding round, with contributions from the European Innovation Council Fund (EIC Fund) and support from current investors, Cascara Ventures and Lednil.
Go deeper with GlobalData
This capital injection will enable Surgify Medical to build on its Nordic market launch and extend its operations into the European Union (EU) and the US, where the technology is already being adopted in hospitals.
According to the company, conventional surgical drills pose a risk of damaging critical soft tissues, potentially leading to severe patient injuries.
The company’s technology claims to address this issue by offering a safer alternative that cuts bone while safeguarding soft tissues, such as nerves and blood vessels.
It not only enhances precision but also integrates into standard clinical workflows seamlessly, earning the approval of both the Medical Device Regulation (MDR) and the Food and Drug Administration (FDA).
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe company noted that surgeons have expressed a preference for Surgify Halo due to its easy usage.
Surgify Medical CEO and co-founder Visa Sippola said: “ZEISS brings unparalleled experience in surgical technology and a global network, while the EIC’s continued support and earlier grant financing underscore the European innovation ecosystem’s confidence in our solution.
“With this funding and regulatory approvals in both the EU and the US, we are well-positioned to bring our unique technology to more surgeons and patients internationally.”
Beyond its immediate applications in neck, spine and head surgeries, the Surgify Halo technology holds applications in the field of robotic surgery by facilitating automated bone resection.
With a total of €14m raised so far and offices in Finland, the US, Denmark and Sweden, Surgify Medical is focused on transforming bone surgery by making it faster, safer and more accurate.
